Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.

Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, Goguen LA, Sullivan CA, Costello R, Case MA, Posner MR.

Oncologist. 2003;8(1):35-44. Review.

2.

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.

Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M.

Cancer. 2003 Jan 15;97(2):412-8.

3.

The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck.

Posner MR, Colevas AD, Tishler RB.

Semin Oncol. 2000 Aug;27(4 Suppl 8):13-24. Review.

PMID:
10952434
4.

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI; TAX 324 Study Group.

N Engl J Med. 2007 Oct 25;357(17):1705-15.

5.

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL; EORTC 24971/TAX 323 Study Group.

N Engl J Med. 2007 Oct 25;357(17):1695-704.

6.

A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.

Tishler RB, Norris CM Jr, Colevas AD, Lamb CC, Karp D, Busse PM, Nixon A, Frankenthaler R, Lake-Willcutt B, Costello R, Case M, Posner MR.

Cancer. 2002 Oct 1;95(7):1472-81.

7.

[Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].

Chilimoniuk M, Olszewska E, Maksimowicz T.

Pol Merkur Lekarski. 2010 Dec;29(174):357-60. Polish.

PMID:
21298984
8.

Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.

Tsai TL, Chu PY, Tai SK, Wang YF, Yang MH, Wang LW, Lirng JF, Chang SY.

Jpn J Clin Oncol. 2011 Oct;41(10):1182-93. doi: 10.1093/jjco/hyr124. Epub 2011 Aug 23.

PMID:
21862506
9.

Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.

Baghi M, Hambek M, May A, Radeloff A, Gstoettner W, Knecht R.

Anticancer Res. 2006 Jan-Feb;26(1B):559-63.

10.

Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.

Schultz JD, Bran G, Anders C, Sadick H, Faber A, Hörmann K, Sauter A.

Oncol Rep. 2010 Nov;24(5):1213-6.

PMID:
20878112
11.

Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?

Paccagnella A, Mastromauro C, D'Amanzo P, Ghi MG.

Oncologist. 2010;15 Suppl 3:8-12. doi: 10.1634/theoncologist.2010-S3-08.

12.

Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.

Merlano M, Russi EG, Numico G, Colantonio I, Garrone O, Pelissero A, Granetto C, Gasco M, Di Costanzo G, Heouaine A, Vigna Taglianti R, Cipolat M.

Radiother Oncol. 2005 May;75(2):193-6. Epub 2004 Dec 9.

PMID:
16086909
13.

Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.

Ghi MG, Paccagnella A, D'Amanzo P, Mione CA, Fasan S, Paro S, Mastromauro C, Carnuccio R, Turcato G, Gatti C, Pallini A, Nascimben O, Biason R, Oniga F, Medici M, Rossi F, Fila G.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):481-7.

PMID:
15145166
14.

Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN).

Colevas AD, Norris CM, Tishler RB, Lamb CC, Fried MP, Goguen LA, Gopal HV, Costello R, Read R, Adak S, Posner MR.

Am J Clin Oncol. 2002 Apr;25(2):153-9.

PMID:
11943893
15.

Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.

Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.

Cancer Chemother Pharmacol. 2008 Dec;63(1):9-17. doi: 10.1007/s00280-008-0702-1. Epub 2008 Mar 15.

PMID:
18343925
16.

Taxanes in the treatment of head and neck cancer.

Schrijvers D, Vermorken JB.

Curr Opin Oncol. 2005 May;17(3):218-24. Review.

PMID:
15818164
17.

[Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].

Nishio M, Kagami Y, Narimatsu N, Asano K, Sanbe S, Somekawa Y.

Gan To Kagaku Ryoho. 1989 Sep;16(9):3111-8. Japanese.

PMID:
2476971
18.

[Recent regimen of chemotherapy for advanced head and neck carcinomas].

Tsukuda M.

Gan To Kagaku Ryoho. 2000 Mar;27(3):341-7. Review. Japanese.

PMID:
10740626
20.

Induction chemotherapy for head and neck cancer: recent data.

Vokes EE.

Oncologist. 2010;15 Suppl 3:3-7. doi: 10.1634/theoncologist.2010-S3-03. Review.

Supplemental Content

Support Center